These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19735073)

  • 1. A 1-step Bayesian predictive approach for evaluating in vitro in vivo correlation (IVIVC).
    Gould AL; Agrawal NG; Goel TV; Fitzpatrick S
    Biopharm Drug Dispos; 2009 Oct; 30(7):366-88. PubMed ID: 19735073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.
    Kesisoglou F; Xia B; Agrawal NG
    AAPS J; 2015 Nov; 17(6):1492-500. PubMed ID: 26290380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convolution-based approaches for in vivo-in vitro correlation modeling.
    Gillespie WR
    Adv Exp Med Biol; 1997; 423():53-65. PubMed ID: 9269483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approach.
    Sánchez-Dengra B; González-García I; González-Álvarez M; González-Álvarez I; Bermejo M
    Eur J Pharm Biopharm; 2021 Jan; 158():185-197. PubMed ID: 33248267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications.
    Modi NB; Lam A; Lindemulder E; Wang B; Gupta SK
    Biopharm Drug Dispos; 2000 Nov; 21(8):321-6. PubMed ID: 11514951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.
    Zhang Y; Liu H; Tang MJ; Ho NJ; Shek TL; Yang Z; Zuo Z
    AAPS J; 2021 Mar; 23(2):38. PubMed ID: 33665728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Sci; 2001 Aug; 90(8):1176-85. PubMed ID: 11536222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions.
    Margolskee A; Darwich AS; Galetin A; Rostami-Hodjegan A; Aarons L
    AAPS J; 2016 Mar; 18(2):321-32. PubMed ID: 26667356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian knowledge integration for an in vitro-in vivo correlation model.
    Erhardt EM; Ursino M; Biewenga J; Jacobs T; Gasparini M
    Biom J; 2019 Sep; 61(5):1104-1119. PubMed ID: 30259557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct, differential-equation-based in-vitro-in-vivo correlation (IVIVC) method.
    Buchwald P
    J Pharm Pharmacol; 2003 Apr; 55(4):495-504. PubMed ID: 12803771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2012 Oct; 101(10):3593-603. PubMed ID: 22786667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Dissolution as a Tool for Formulation Selection: Telmisartan Two-Step IVIVC.
    Ruiz Picazo A; Martinez-Martinez MT; Colón-Useche S; Iriarte R; Sánchez-Dengra B; González-Álvarez M; García-Arieta A; González-Álvarez I; Bermejo M
    Mol Pharm; 2018 Jun; 15(6):2307-2315. PubMed ID: 29746133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
    Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of in vitro-in vivo correlation for encapsulated metoprolol tartrate.
    Khaled AA; Pervaiz K; Karim S; Farzana K; Murtaza G
    Acta Pol Pharm; 2013; 70(4):743-7. PubMed ID: 23923398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IVIVC approach based on carbamazepine bioequivalence studies combination.
    González-García I; Mangas-Sanjuan V; Merino-Sanjuán M; Álvarez-Álvarez C; Díaz-Garzón Marco J; Rodríguez-Bonnín MA; Langguth T; Torrado-Durán JJ; Langguth P; García-Arieta A; Bermejo M
    Pharmazie; 2017 Aug; 72(8):449-455. PubMed ID: 29441903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
    Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
    Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2014 Feb; 103(2):367-77. PubMed ID: 24301077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).
    Dutta S; Qiu Y; Samara E; Cao G; Granneman GR
    J Pharm Sci; 2005 Sep; 94(9):1949-56. PubMed ID: 16052544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.